Archives

From April 23-27, Fighting Blindness Canada attended one of the largest vision research conferences in the world: the Association for Research in Vision and Ophthalmology (ARVO). It was illuminating to learn about…
READ MORE about Clinical Trial Advances for IRD, AMD and glaucoma
Matthew is at least the fourth generation in his family to be affected by retinitis pigmentosa (RP), a rare genetic eye disease that over time makes cells in the retina break down,…
READ MORE about Matthew’s Story and The Value of Planned Giving
May Vision Health Month is a time when Canadians bring awareness to eye health and the prevention of vision loss. Throughout the month of May, we will be highlighting our mission of…
READ MORE about May is Vision Health Month
Fighting Blindness Canada would like to share that on June 2, 2023, Ann Morrison, Director of Philanthropy, will be retiring. We are happy for Ann to start this next chapter of her…
READ MORE about Announcing the retirement of Ann Morrison, Director of Philanthropy
Luxturna is the first gene therapy treatment approved for an inherited retinal disease in Canada. The treatment is for people who have Leber congenital amaurosis (LCA) or retinitis pigmentosa (RP) caused by…
READ MORE about Canadians now have access to Luxturna!
Accessible Media Inc. (AMI) is a not-for-profit media company, that entertains, informs, and empowers Canadians who are blind or partially sighted. As Fighting Blindness Canada’s national media partner, we had the opportunity…
READ MORE about Empowering the disability community through accessible mediaJoin the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.